First Pass

38 stories from 12 sources

Ebola accelerates as health systems strain across outbreaks and markets

Day’s Recap

Supporting Articles

4:52 PMAl Jazeera

WHO chief: Ebola outbreak in DRC spreading at ‘unprecedented rate’

Summary

The WHO chief says an Ebola outbreak in the Democratic Republic of the Congo is spreading at an unprecedented rate. The outbreak has killed 1,751 people.

The speed of transmission and scale of deaths indicate that containment efforts are falling behind

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Rapid transmission and a high death toll increase the risk that local health systems will be overwhelmed and the outbreak will spread beyond affected areas.

10:04 AMBBC

DR Congo river boat under quarantine for Ebola after five deaths

Summary

A river boat in the Democratic Republic of Congo has been placed under quarantine after five deaths, with health officials screening all passengers for Ebola.

The quarantine reflects the risk that river transport could carry Ebola from an affected area

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A mobile outbreak on a major river route could spread the virus faster than local health systems can detect it.

9:07 AMAl Jazeera

DR Congo Ebola health workers protest unpaid wages as deaths surpass 1,800

Summary

Health workers in the Democratic Republic of Congo are protesting unpaid wages as Ebola deaths exceed 1,800 and the outbreak spreads into remote areas.

Unpaid workers are weakening the response at the moment the virus is expanding beyond easier-to-reach

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A public-health response cannot contain Ebola when the workforce responsible for it is demoralized and unsupported.

7:20 AMAl Jazeera

Ebola outbreak accelerates as healthcare workers strike over pay

Summary

An Ebola outbreak is worsening while healthcare workers strike over unpaid or inadequate compensation. The labor dispute is disrupting the response as the disease continues to spread.

The strike removes capacity from the exact services needed to contain Ebola, including case detection,

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A weakened health workforce can turn a containable Ebola outbreak into a broader regional emergency.

8:30 AMAl Jazeera

Deadliest form of malnutrition has reached critical levels in Afghanistan

Summary

Child wasting, the most dangerous form of acute malnutrition, has reached critical levels in one-third of Afghanistan’s provinces.

The scale of severe wasting signals a rapidly worsening nutrition crisis, especially for children who

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Severe child wasting becomes fatal quickly, so delayed aid will translate directly into preventable deaths.

2:47 PMAl Jazeera

CDC says US salmonella outbreak tied to jalapeno peppers from Mexico

Summary

The CDC linked a salmonella outbreak that has sickened hundreds of people across 27 US states to jalapeno peppers imported from Mexico.

The investigation shifts attention from individual illnesses to a potentially contaminated food supply spanning multiple

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A widely distributed ingredient can turn a localized contamination problem into a multistate public-health threat.

9:13 AMCNBC

Mexican jalapenos tied to Salmonella outbreak in 27 U.S. states

Summary

CDC and FDA are investigating a Salmonella outbreak linked to jalapenos from Mexico that has sickened 345 people across 27 states. A recall is underway.

The outbreak's multistate spread has triggered a coordinated federal investigation and product recall. Consumers, retailers,

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

The scale of the outbreak raises the risk of further illnesses before contaminated products are fully identified and removed.

3:59 PMStat News

STAT+: FDA approves Replimune melanoma drug previously rejected twice

Summary

The FDA approved Replimune's treatment for advanced melanoma after rejecting the drug twice. The decision delivers a major regulatory win for the company and patient advocates after a prolonged review process.

The approval reverses the drug's regulatory trajectory and gives patients with advanced melanoma another treatment

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

The decision expands melanoma treatment choices and shows that a twice-rejected therapy can still reach patients after further regulatory review.

3:00 PMStat News

STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts

Summary

An advocacy group says a little-noticed policy change delayed Medicare's selection of a costly AbbVie medicine for price negotiations by seven years. The delay kept the drug outside the immediate reach of the federal price-setting process.

The alleged policy shift could materially extend the period during which Medicare pays the drug's

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A seven-year delay would show how administrative decisions can substantially limit Medicare's ability to reduce spending on blockbuster medicines.

6:55 PMNYT New York

Families Sue New York City Over Deaths in 2025 Legionnaires’ Outbreak

Summary

Families are suing New York City after a Harlem Legionnaires' outbreak linked to two city-owned sites killed residents and sickened others. The lawsuits allege that improperly maintained cooling towers released dangerous bacteria.

The claims place responsibility for the deaths on failures at city-controlled facilities, rather than treating

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

The suits could determine whether city agencies and contractors face substantial liability for preventable Legionnaires' infections.

3 stories · 3 sources

12:28 PMCNBC

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Summary

Eli Lilly expanded its lead in the obesity-drug market after its latest earnings report, while Novo Nordisk continued working to recover market share and rebuild confidence in its pipeline. The results sharpened the contrast between the companies' commercial momentum.

Lilly now has more room to shape pricing, supply, and prescribing trends in the obesity

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

The obesity-drug race is becoming a test of sustained product execution, not just which company reaches patients first.

8:31 AMFortune

Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult

Summary

Wegovy transformed Novo Nordisk into Europe’s most valuable company, but a failed clinical trial and intensifying US competition have complicated its growth outlook. The company is betting on continued innovation and oral weight-loss drugs to find its next major product.

Novo Nordisk now must reduce its dependence on Wegovy while defending its position in an

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

The company’s valuation and future growth now depend on turning obesity-drug leadership into a broader product pipeline.

3:35 PMGothamist

West Nile virus detected in nearly twice as many NYC mosquito pools as last year

Summary

Health officials found West Nile virus in nearly twice as many tested mosquito pools as at the same point last year. They are expanding mosquito control and urging residents to use repellent and remove standing water.

The increase broadens the period and geography in which New Yorkers face mosquito-borne disease risk.

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

More infected mosquito pools raise the chance of human cases and make household prevention part of the city's response.

Other Developments

A curated list of other prominent stories from this day.

5:28 PMCNBC

Michigan eases lettuce advice as state health department says cyclosporiasis reports decline

Summary

Michigan is easing its lettuce-related public health advice as reports of cyclosporiasis decline. The outbreak has been linked to two deaths, both involving people with significant underlying health conditions.

The decline in reports signals that the outbreak may have passed its peak, but the

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Fewer cases may support relaxed consumer advice, but the deaths keep the outbreak a serious concern for vulnerable populations.

1:56 PMBloomberg Markets

Hospital Sector to See K-Shaped Path, Federal Cuts Expected

Summary

US hospitals are emerging from a period of financial recovery just as federal policy changes and rising demand from aging baby boomers begin to pressure the sector.

The recovery is likely to split the industry rather than lift it evenly. Well-capitalized systems

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Federal cuts could widen the gap between financially resilient health systems and hospitals already operating with limited margin.

1:40 PMPYMNTS

GoodRx and Oscar Health Tout Tech as Consumer Needs Change

Summary

Oscar Health reported record first-half profitability and a 70% increase in revenue to $4.9 billion, while Oscar and GoodRx emphasized technology as customer needs evolve.

Oscar's results show that scale and technology can support rapid growth as consumers demand more

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Healthcare technology is becoming a competitive tool for controlling costs and retaining consumers as insurance and medication needs change.

11:53 AMEconomic Times

Fortis Healthcare Q1 Results: Profit rises 2.3% to Rs 273 crore

Summary

Fortis Healthcare’s consolidated first-quarter profit rose 2.3% to Rs 273 crore, while revenue increased 17.5% to Rs 2,545 crore. Hospital operations and diagnostics supported the growth, alongside continued infrastructure investment.

Revenue growth substantially outpaced profit growth, indicating that margin expansion remains limited despite strong operating

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Fortis is growing quickly, but investors will need evidence that higher revenue converts into stronger margins.

11:37 AMBloomberg Markets

Roivant Expects FDA to Approve First Major Drug

Summary

Roivant CEO Matt Gline expects the FDA to approve the company's drug for a debilitating skin disease, with a commercial launch targeted for September.

FDA approval would give Roivant its first major commercial product and shift the company from

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Approval could mark Roivant's transition into a commercial pharmaceutical company and establish its first meaningful revenue stream.

11:00 AMStat News

STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug development

Summary

A new study identifies a previously unknown role for tau in the neurodegenerative processes associated with Alzheimer's disease. The finding adds biological support to efforts to develop drugs that target tau.

The result broadens the case for tau-directed treatments beyond simply removing tau aggregates from the

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A clearer map of tau's role could expand the targets and strategies available in Alzheimer's drug development.

9:49 AMStat News

STAT+: Two FDA approvals — a new drug and a new vaccine

Summary

The FDA approved Takeda's narcolepsy drug and the first mRNA flu vaccine, alongside other biotechnology developments. The approvals add new options in sleep medicine and influenza prevention.

The decisions extend mRNA technology into seasonal influenza and give narcolepsy patients another treatment option.

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

The approvals broaden the commercial and clinical reach of two technology platforms with implications beyond their initial products.

9:47 AMStat News

U.S. moves to shut a Kentucky organ donation group, citing safety failures

Summary

Federal authorities are moving to close a Kentucky organ donation organization accused of pursuing organ recovery from patients who unexpectedly showed signs of life.

The decisive issue is a breakdown in safeguards meant to confirm death before organ retrieval.

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Organ donation depends on public confidence that death determinations are independent, accurate, and irreversible.

9:38 AMStat News

Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response

Summary

The article calls for an independent, transparent investigation into the U.S. Covid-19 response, modeled on the commission created after the September 11 attacks.

The proposal would move the reckoning over Covid from partisan debate to a formal review

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Without a credible review, the U.S. risks repeating the institutional failures that shaped its pandemic response.

8:43 AMScienceDaily

Major study challenges long-held fears about acetaminophen and ibuprofen use in babies

Summary

A study of nearly 4,000 infants found no meaningful safety difference between acetaminophen and ibuprofen during infancy. Neither drug was linked to eczema or bronchiolitis, and the researchers reported no serious drug-related side effects.

The results weaken concerns that either common fever and pain medicine causes these respiratory or

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Parents and clinicians gain stronger evidence for using either medicine when an infant needs symptom relief, within appropriate dosing limits.

6:30 AMGothamist

Loss of Haitian caregivers leaves void NY nursing homes, patients will 'struggle to fill'

Summary

The end of Temporary Protected Status for Haitian healthcare workers is raising concern among New York nursing homes, caregivers and patient advocates. Employers and frontline workers warn that losing Haitian staff will deepen workforce shortages and affect patient care.

Ending the humanitarian protection program removes workers from a sector already struggling to recruit and

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Immigration policy is directly changing the capacity and reliability of New York's long-term-care system.

6:23 AMScienceDaily

Nearly half of dementia cases may be linked to risks you can change

Summary

A long-term brain study linked smoking, high blood pressure, heart disease, and elevated blood lipids to brain damage associated with vascular dementia. The findings suggest that controlling several modifiable risks could delay or reduce dementia-related injury.

The decisive shift is from treating dementia risk as largely fixed to targeting a cluster

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Dementia prevention may be more actionable because many of its major risk factors are already measurable and treatable.

5:50 AMScienceDaily

A drug already used for osteoporosis blocked spinal damage in a new study

Summary

Researchers linked a faulty collagen-related gene to mineral buildup and spinal fusion in zebrafish, changes that resemble human disc disease. An existing osteoporosis drug, along with a treatment targeting fat metabolism, reduced the damage.

The study shifts spinal degeneration research toward mechanisms that may be treatable before irreversible fusion

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A treatment already used in osteoporosis could offer a faster route to new therapies for degenerative back disease.

5:40 AMCNBC

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

Summary

Preliminary reports of talks between AstraZeneca and Bristol Myers Squibb sent shares higher and revived debate about a potential deal. Such a transaction would represent a major consolidation move among large drugmakers.

AstraZeneca appears to be weighing U.S. scale over the recent preference for smaller, targeted acquisitions.

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

A transaction could reshape Big Pharma competition and signal that large-scale consolidation is returning.

2:35 AMBloomberg Markets

Manipal Health Eyes India Expansion After IPO Debut

Summary

Manipal Health Enterprises plans to use proceeds from its IPO to reduce debt and fund expansion across India. Its leadership also discussed valuation concerns, acquisitions and a continued focus on the domestic market.

The IPO gives Manipal Health capital to pursue growth while strengthening its balance sheet. That

Unlock the full First Pass Analysis to get a better understanding of why this story matters

Why it matters

Manipal's post-IPO capital allocation will shape both its competitive position and the pace of consolidation in Indian healthcare.

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!